5 Medicines, namely, medicines for the treatment of bone diseases; Medicines for the treatment of immune system related diseases and disorders; Medicines for the prevention of autoimmune diseases; Medicines for treating rheumatological diseases; Medicines for the treatment of cancer; Medicines for activating cellular function; Medicines for treating malignant tumors; Medicines for immunity adjustment; Medicines for regulating the immune system; Medicines for the treatment of autoimmune diseases; Medicines for use in chemotherapy; Medicines for use in oncology; Medicines and pharmaceutical substances for the treatment of cancer; Medicines and pharmaceutical substances for the prevention of cancer; Medicines and pharmaceutical substances for use in oncology; Medicines for the treatment of Parkinson's disease; Medicines for the treatment of central nervous system diseases; Medicines for the treatment of multiple sclerosis; Medicines for peripheral nervous system; Medicines for the treatment of epilepsy; Medicines for treating sensory organ disorders; Medicines for the prevention of disorders of the immune system; Medicines for use in tissue transplantation; Medicines for use in organ transplantation; Medicines for the prevention of disorders of the nervous system; Medicines for the prevention of diseases of the nervous system; Diagnostic preparations for medical purposes and diagnostic materials, namely, diagnostic agents for medical purposes, diagnostic substances for medical purposes; Biochemical preparations for medical use, namely, for treatment of cancer; Chemical preparations for medical purposes, namely, for treatment of cancer; Cardiovascular agents for medical purposes; Medicinal healthcare preparations for treatment of cancer; Medical preparations for treatment of cancer; Cellular function activating agents for medical purposes; Nucleic acid sequences for medical purposes; Organotherapeutics; Reagents for medical use; Stem cells for medical use; Pre- filled syringes for medical purposes, filled with medicine for treatment of cancer; Anti-cancer drugs, namely, Anti-cancer preparations, Pharmaceutical products for the prevention and treatment of cancer; Medicines for intestinal disorders; Medicines for the treatment and prevention of lung disorders; Medicines for the treatment and prevention of liver disorders; Medicines for the treatment and prevention of kidney disorders; Medicines for the treatment and prevention of reproductive organ disorders; Medicines for the treatment and prevention of heart and heart valve disorders; Medicines for genetic reprogramming of cells and organs for prevention of intestinal disorders; Medicines for the treatment of the nervous system; Medicines for the treatment of brain and spinal cord trauma including paraplegia; Biopharmaceuticals for the treatment of cancer; Biotechnological preparations for medical use, namely, genetically engineered biological preparations for the treatment of cancer; Chemico-pharmaceutical preparations for treatment of cancer; Chemicals for pharmaceutical use, namely, chemical reagents for pharmaceutical or medical purposes; Chemical preparations for pharmaceutical medical purposes for treatment of cancer; Chemical preparations for pharmaceutical purposes, namely, for treatment of cancer; Anti-cancer preparations of chemical origin; Chemotherapeutics; Cardiovascular treatment preparations; Immunomodulators being a type of pharmaceutical preparation for the treatment of immune system related diseases and disorder; Immunoassay reagents for medical use; Immunostimulants; Antitumor drugs, namely, Tumor suppressing agents; Nervines, namely, for treatment of nervous system; Tissue-regenerative pharmaceutical preparations; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for treating rheumatological diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for activating cellular function; Pharmaceutical preparations for treating malignant tumors; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of epilepsy; Pharmaceutical preparations for treating sensory organ disorders; Pharmaceutical preparations for the prevention of disorders of the immune system; Pharmaceutical preparations for use in tissue transplantation; Pharmaceutical preparations for use in organ transplantation; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for the prevention of diseases of the nervous system; Compounds for treating cancer, namely, Drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for treating cancer, Biometallic compounds being a component in pharmaceutical preparations for treating cancer; Central nervous system stimulants; Tumor suppressing agents; Ethical medicinal preparations for treatment of cancer, use in dermatology; Cytostatics for medical purposes; Bacteriological preparations for medical use; Biological reagents for medical use; Diagnostic chemical reagents for medical use; Chemical preparations for testing blood for medical purposes; Chemical preparations for use in DNA analysis for medical purposes; Pharmaceuticals for the therapy and prophylaxis of neurodegenerative diseases; Pharmaceuticals for the therapy and prophylaxis of Morbus Alzheimer, Morbus Parkinson, Morbus Huntington, amyotrophic lateral sclerosis (ALS), acquired immunodeficiency syndrome AIDS dementia, Retinitis pigmentosa, spinal muscular atrophy, cerebellar degeneration, fragile X-associated tremor/ataxia syndrome (FXTAS), progressive supranuclear palsy (PSP), striatonigral degeneration (SND), Shy-Drager syndrome (SDS); Pharmaceuticals for the therapy and prophylaxis of multiple system atrophy (MSA), parkinsonian type (MSA-P) or formerly olivopontocerebellar atrophy (OPCA), all of the entities of hydrocephalus including normal pressure hydrocephalus, paraplegia, condition after hypoxia and resuscitation, cognitive deficiencies after inflammatory or infectious CNS disorders; Pharmaceuticals for the therapy and prophylaxis of forms of fibrotic tissue transformation including presbycusis, presbyopia, glaucoma, forms of pulmonary fibrosis, including Idiopathic pulmonary fibrosis (IPF), liver cirrhosis, kidney diseases, gynecological disorders, keloid formations after trauma; Chemical and biological products, namely, diagnostic preparations for medical purposes for diagnosing neurodegenerative diseases, pulmonary diseases, liver cirrhosis, oncological diseases; Diagnostic preparations, in particular, diagnostics preparations for medical purposes and for diagnosing central nervous system (CNS) disorders, forms of fibrotic tissue transformations, pulmonary diseases, liver cirrhosis, kidney diseases, gynecological disorders, oncological diseases